Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Neuropsychological correlates of suboptimal adherence to metformin.

Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA.

J Behav Med. 2003 Aug;26(4):349-60.

PMID:
12921008
2.
3.

Electronic monitoring and counseling to improve medication adherence.

Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA.

Behav Res Ther. 2004 Apr;42(4):409-22.

PMID:
14998735
4.

Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control study.

Penning-van Beest FJ, Wolffenbuttel BH, Herings RM.

Clin Drug Investig. 2008;28(8):487-93.

PMID:
18598094
5.

Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study.

Donnelly LA, Morris AD, Pearson ER.

Diabetes Obes Metab. 2009 Apr;11(4):338-42. doi: 10.1111/j.1463-1326.2008.00973.x.

PMID:
19267712
6.
9.
10.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
11.

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.

PMID:
16291411
12.

Glyburide/metformin HCl clinical overview.

Seymour A.

Manag Care. 2001 Feb;10(2 Suppl):11-6. Review. No abstract available.

13.

Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.

Williams-Herman D, Johnson J, Teng R, Luo E, Davies MJ, Kaufman KD, Goldstein BJ, Amatruda JM.

Curr Med Res Opin. 2009 Mar;25(3):569-83. doi: 10.1185/03007990802705679 .

PMID:
19232032
14.

Patient adherence improves glycemic control.

Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, Gallina DL, Barnes C, Phillips LS.

Diabetes Educ. 2005 Mar-Apr;31(2):240-50.

PMID:
15797853
16.

Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.

Grant R, Adams AS, Trinacty CM, Zhang F, Kleinman K, Soumerai SB, Meigs JB, Ross-Degnan D.

Diabetes Care. 2007 Apr;30(4):807-12. Epub 2007 Jan 26.

PMID:
17259469
17.

Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, Holst EM, Nichol MB, Shi SG, Livengood KB, Walden S, Lubowski TJ.

Ann Pharmacother. 2004 Sep;38(9):1357-62. Epub 2004 Jul 6.

PMID:
15238621
18.
19.

[Blood sugar inspite of maximal metformin dosage. New fixed combination forces HbA1c down].

[No authors listed]

MMW Fortschr Med. 2003 Dec 11;145(50):54. German. No abstract available.

PMID:
14963975
20.

Supplemental Content

Support Center